FDA OKs Masimo wearable patient sensor

Masimo (NASDAQ:MASI) announces that the FDA has granted 510(k) clearance to Centroid, a wireless wearable sensor that monitors patient orientation, activity and respiration rate.

The device, paired with the Root Patient Monitoring and Connectivity Platform via Bluetooth, helps clinicians monitor patient position to avoid preventable pressure ulcers and can alert them to sudden movements such as falls.

https://seekingalpha.com/news/3586338-fda-oks-masimo-wearable-patient-sensor